Andrew M. Evens, Ann Vanderplas, Ann S. LaCasce, Allison L. Crosby, Auayporn P. Nademanee, Mark S. Kaminski, Gregory A. Abel, Michael Millenson, Myron S. Czuczman, Maria A. Rodriguez, Joyce Niland, Andrew D. Zelenetz, Leo I. Gordon and Jonathan W. Friedberg Stem cell transplantation for follicular lymphoma relapsed/refractory after prior rituximab Cancer 119
Article first published online: 6 AUG 2013 | DOI: 10.1002/cncr.28243
We identified several critical prognostic factors that predicted survival within and across autologous stem cell transplantation (autoSCT) and allogeneic SCT (alloSCT) cohorts and a prognostic survival model was created for patients with relapsed/refractory follicular lymphoma in the post-rituximab era. Additionally, overall survival appeared improved for autoSCT versus alloSCT including on multivariate analysis and with propensity scoring/matching.
Complete the form below and we will send an e-mail message containing a link to the selected article on your behalf
Required = Required Field